Technology

The following in-house and industry standard technologies are available for InhibOx projects. The DrugFinder service is built from a unique and validated combination of these software tools.

Molecular Databases

InhibOx has invested in establishing robust and secure processes for building and updating its Scopius database of commercially-available and easily synthesized compounds. Scopius includes CSpace, an evolving database of six million unique commercially available compounds, from over 60 vendors, canonically standardized and updated on a continuous basis. Click here to read more...

Ligand-based Virtual Screening

The use of  ligand-based methods (where the structure of an active compound is known) is an alternative to ligand-protein docking (where the conformation of the receptor is known). When compared to docking methods, shape-based methods are at least as useful at recovering alternative active molecules from a given set and rely much less on the calculation of the affinity of molecules to a receptor. Click here to read more...

Ligand Protein Docking

Ligand-protein docking methods attempt to identify optimal positions, orientations  and conformations of a ligand or small molecule with respect to a given protein receptor or enzyme.  InhibOx offers extensive expertise and a range of solutions in ligand-protein docking. Click here to read more...

Hardware Resources

InhibOx maintains a large cluster of in-house rack-based servers comprising over 150 processing nodes. Additionally, computations can be expanded onto cloud-based resources, such as Amazon EC2, as required.